Cargando…

Primary malignant pericardial tumour in Lynch syndrome

BACKGROUND: This case represents the first report of malignant primary cardiac tumour in a patient with Lynch Syndrome associated with MSH2 pathogenic variant. CASE PRESENTATION: A 57-year-old woman with previous ovarian cystadenocarcinoma was admitted to the emergency room for hematic pericardial e...

Descripción completa

Detalles Bibliográficos
Autores principales: Paolisso, Pasquale, Saturi, Giulia, Foà, Alberto, Saponara, Maristella, Nannini, Margherita, Pantaleo, Maria Abbondanza, Leone, Ornella, Turchetti, Daniela, Calistri, Daniele, Savini, Carlo, Pacini, Davide, Pizzi, Carmine, Galiè, Nazzareno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059379/
https://www.ncbi.nlm.nih.gov/pubmed/32143595
http://dx.doi.org/10.1186/s12885-020-6677-y
Descripción
Sumario:BACKGROUND: This case represents the first report of malignant primary cardiac tumour in a patient with Lynch Syndrome associated with MSH2 pathogenic variant. CASE PRESENTATION: A 57-year-old woman with previous ovarian cystadenocarcinoma was admitted to the emergency room for hematic pericardial effusion. Multimodal diagnostic imaging revealed two solid pericardial vascularized masses. After pericardiectomy, the final histological diagnosis was poorly differentiated pleomorphic sarcomatoid carcinoma. During follow-up she developed an ampulla of Vater adenocarcinoma. Genetic analysis identified an MSH2 pathogenic variant. CONCLUSION: This case contributes to expand the tumour spectrum of Lynch syndrome, suggesting that MSH2 pathogenic variants cause a more complex multi-tumour cancer syndrome than the classic Lynch Syndrome. In MSH2 variant carriers, symptoms such as dyspnoea and chest discomfort might alert for rare tumours and a focused cardiac evaluation should be considered.